(lp0
S'MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors PR Newswire  - Mar 19, 2017 MARIETTA, Ga., March 19, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market&nbsp;...'
p1
aS'Today Analysts Focus on MiMedx Group, Inc. , Microsemi Corporation  StockNewsJournal - 19 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p2
aS"MiMedx To Present At Canaccord's 12th Annual Musculoskeletal Conference PR Newswire  - Mar 8, 2017 MARIETTA, Ga., March 8, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human placental tissue allografts and other birth tissues, human skin and bone, and patent-protected processes and&nbsp;...MiMedx Group Inc  Earns Overweight Rating from Analysts at Piper Jaffray ... - The Cerbat GemMiMedx Group, Inc.  held by 41 SEC 13F Filers - Post Analyst"
p3
aS'MiMedx Group, Inc.: A Fundamentally Solid Biomaterials Company Poised For Growth Seeking Alpha - Dec 9, 2016 I recommend buying a long position in MiMedx Group, Inc., trading at $8.29 per share at the time this analysis was conducted, as I believe the market is undervaluing this security by 30-40%.'
p4
aS'MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo PR Newswire  - Jul 25, 2016 MARIETTA, Ga., July 25, 2016 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...'
p5
aS'MiMedx to Host Shareholder call on March 9, 2017 to present various strategic ... PR Newswire  - Mar 2, 2017 MARIETTA, Ga., March 2, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and&nbsp;...'
p6
aS'MiMedx Files Lawsuits Against Two Additional Former Sales Employees For Breach ... PR Newswire  - Dec 30, 2016 MARIETTA, Ga., Dec. 30, 2016 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...'
p7
aS'Scientific Study Confirms MiMedx dHACM Allograft Promotes Cardiac Repair ... PR Newswire  - Jan 24, 2017 MARIETTA, Ga., Jan. 24, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...MiMedx touts data from study of AmnioFix, EpiFix allograft - Mass Device'
p8
aS"MiMedx Board of Directors Authorizes $10 Million Increase to the Company's ... PR Newswire  - Feb 6, 2017 MARIETTA, Ga., Feb. 6, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;..."
p9
aS'Average Brokerage Rating Of PDC Energy, Inc. , MiMedx Group, Inc.  The USA Commerce - 20 hours ago Latest closing price was -11.64% below its 50-day moving average and -3.93% below its 200-day moving average. On 03/21/2017 close, MiMedx Group, Inc.  plummeted -1.01% to $8.85. The stock currently has a Market Cap of $963.23M.'
p10
a.